MedPath

Optimata Ltd.

Optimata Ltd. logo
🇮🇱Israel
Ownership
Private
Established
2000-01-01
Employees
51
Market Cap
-
Website
http://www.optimata.com

Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy

Conditions
Melanoma
Interventions
Device: ML-PrediCare
First Posted Date
2015-10-20
Last Posted Date
2016-09-27
Lead Sponsor
Optimata Ltd.
Target Recruit Count
500
Registration Number
NCT02581228
Locations
🇮🇱

Optimata Ltd., Bene-Atarot, Israel

Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

Conditions
Non-Small Cell Lung Cancer
Colon Cancer
Small Cell Lung Cancer
Breast Cancer
Prostate Cancer
Interventions
Device: PrediCare
First Posted Date
2015-10-16
Last Posted Date
2017-04-04
Lead Sponsor
Optimata Ltd.
Target Recruit Count
5000
Registration Number
NCT02577627
Locations
🇮🇱

Optimata Ltd., Bene-Atarot, Israel

© Copyright 2025. All Rights Reserved by MedPath